top of page
Search
Biologics R&D: select news
Proteome-wide reverse vaccinology to identify potential vaccine candidates against Staphylococcus aureus
https://pubmed.ncbi.nlm.nih.gov/40435577/
jeanfrancoismaison
May 291 min read
Â
Â
Â
A phase I, randomized, placebo-controlled, double-blind, ascending-dose and single-center study to evaluate immunogenicity and safety of a live attenuated tetravalent dengue vaccine (KD-382) in Flaviv
https://pubmed.ncbi.nlm.nih.gov/40435636/
jeanfrancoismaison
May 291 min read
Â
Â
Â
A spray dried replicon vaccine platform for pandemic response
https://pubmed.ncbi.nlm.nih.gov/40436220/
jeanfrancoismaison
May 291 min read
Â
Â
Â
Cancer vaccine trial evaluations: immunobridging and potential immunological endpoints
https://pubmed.ncbi.nlm.nih.gov/40438385/
jeanfrancoismaison
May 291 min read
Â
Â
Â
A Similar Nonclinical Safety Evaluation of Prev(e)nar 13 in a Multi-Dose Formulation Containing the Preservative 2-Phenoxyethanol
https://pubmed.ncbi.nlm.nih.gov/40432098/
jeanfrancoismaison
May 291 min read
Â
Â
Â
Porcine Peripheral Blood Mononuclear Cells (PBMCs): Methods of Isolation, Cryopreservation, and Translational Applications in Human Studies
https://pubmed.ncbi.nlm.nih.gov/40429425/
jeanfrancoismaison
May 291 min read
Â
Â
Â
Delineation of the Human Germinal Centre Immune Landscape Using Multiplex Imaging Analysis
https://pubmed.ncbi.nlm.nih.gov/40421691/
jeanfrancoismaison
May 291 min read
Â
Â
Â
Long lived liver-resident memory T cells of biased specificities for abundant sporozoite antigens drive malaria protection by radiation-attenuated sporozoite vaccination
https://pubmed.ncbi.nlm.nih.gov/40424562/
jeanfrancoismaison
May 291 min read
Â
Â
Â
Establishment of a Lassa Fever Specimen Biobank in Nigeria
https://pubmed.ncbi.nlm.nih.gov/40425001/
jeanfrancoismaison
May 291 min read
Â
Â
Â
Whole-genome sequencing, strain composition, and predicted antimicrobial resistance of Streptococcus pneumoniae causing invasive disease in England in 2017-20: a prospective national surveillance stud
https://pubmed.ncbi.nlm.nih.gov/40425021/
jeanfrancoismaison
May 291 min read
Â
Â
Â
A VLPs based vaccine protects against Zika virus infection and prevents cerebral and testicular damage
https://pubmed.ncbi.nlm.nih.gov/40425591/
jeanfrancoismaison
May 291 min read
Â
Â
Â
Integrated in-silico design and in vivo validation of multi-epitope vaccines for norovirus
https://pubmed.ncbi.nlm.nih.gov/40426240/
jeanfrancoismaison
May 291 min read
Â
Â
Â
WHO Workshop Report: Regulatory Science to Inform Clinical Pathways for Shigella Vaccines Intended for Use in Children in Low- and Middle-Income Countries
https://pubmed.ncbi.nlm.nih.gov/40432051/
jeanfrancoismaison
May 291 min read
Â
Â
Â
Considerations for mRNA Product Development, Regulation and Deployment Across the Lifecycle
https://pubmed.ncbi.nlm.nih.gov/40432085/
jeanfrancoismaison
May 291 min read
Â
Â
Â
Emerging Immunotherapies in Lung Cancer: The Latest Advances and the Future of mRNA Vaccines
https://pubmed.ncbi.nlm.nih.gov/40432088/
jeanfrancoismaison
May 291 min read
Â
Â
Â
Dengue Vaccine Development and Deployment into Routine Immunization
https://pubmed.ncbi.nlm.nih.gov/40432095/
jeanfrancoismaison
May 291 min read
Â
Â
Â
Proceedings of the 7th Asia Dengue Summit, June 2024
https://pubmed.ncbi.nlm.nih.gov/40432105/
jeanfrancoismaison
May 291 min read
Â
Â
Â
The New Era of Pneumococcal Vaccination in Adults: What Is Next?
https://pubmed.ncbi.nlm.nih.gov/40432110/
jeanfrancoismaison
May 291 min read
Â
Â
Â
Shigella Mutant with Truncated O-Antigen as an Enteric Multi-Pathogen Vaccine Platform
https://pubmed.ncbi.nlm.nih.gov/40432116/
jeanfrancoismaison
May 291 min read
Â
Â
Â
A Computationally Designed Prefusion Stabilized Human Metapneumovirus Fusion Protein Vaccine Antigen Elicited a Potent Neutralization Response
https://pubmed.ncbi.nlm.nih.gov/40432132/
jeanfrancoismaison
May 291 min read
Â
Â
Â
bottom of page